Morepen Laboratories Limited : transforming to a healthcare company /

Set in India in 2002, the case calls for an assessment of the business direction in which Morepen Laboratories Ltd (MLL) is headed. Under the direction of Sushil Suri, the company was poised for a transformation from being a bulk drug pharmaceutical company to an integrated healthcare company. Advis...

Full description

Bibliographic Details
Main Authors:	Sivaraman, Vasant (Author), Lalwani, Suresh (Author), Jalan, Rohit (Author)
Format:	eBook
Language:	English
Published:	London : NeilsonJournals Publishing, 2007.
Series:	SAGE Knowledge. Cases.
Subjects:	Morepen Laboratories Limited. Suri, Sushil. Pharmaceutical industry > India > Case studies. Integrated delivery of health care > India > Case studies. Strategic planning > Case studies. Financial statements > Case studies. Corporations > Finance > Case studies. Industrie pharmaceutique > Inde > Études de cas. Prestation intégrée de soins > Inde > Études de cas. Planification stratégique > Études de cas. Corporations > Finance Financial statements Integrated delivery of health care Pharmaceutical industry Strategic planning India Electronic books. Case studies Case studies. Études de cas.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Set in India in 2002, the case calls for an assessment of the business direction in which Morepen Laboratories Ltd (MLL) is headed. Under the direction of Sushil Suri, the company was poised for a transformation from being a bulk drug pharmaceutical company to an integrated healthcare company. Advised by leading global consultants, MLL was ahead of its time in stepping into exciting growth sectors. At the same time, the core business was on the verge of large payoffs in a blockbuster market where the patent of the innovator was due to expire. The case offers an opportunity to examine the business strategy of the active pharma substance (loratadine) including elements relating to 'industry analysis', competitive positioning, sustainability, commitments and capabilities. The bold moves by MLL to diversify into new business present a canvas to assess the corporate strategy at work. The case also affords scope for financial statement analysis, financing alternatives and capital structure deliberations.
Item Description:	Originally Published InSivaraman, V., Lalwani, S., & Jalan, R. (2007). Morepen Laboratories Limited: Transforming to a healthcare company. Journal of International Business Education, 3(1), 23-50. JIBE3-0CS3.
Physical Description:	1 online resource : illustrations.
ISBN:	9781526461773 1526461773